Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease
N
Nobukatsu Sawamoto
D
Daisuke Doi
E
Etsuro Nakanishi
M
Masanori Sawamura
T
Takayuki Kikuchi
H
Hodaka Yamakado
Y
Yosuke Taruno
A
Atsushi Shima
Y
Yasutaka Fushimi
T
Tomohisa Okada
T
Tetsuhiro Kikuchi
A
Asuka Morizane
S
Satoe Hiramatsu
T
Takayuki Anazawa
T
Takero Shindo
K
Kentaro Ueno
S
Satoshi Morita
Y
Yoshiki Arakawa
Y
Yuji Nakamoto
S
Susumu Miyamoto
R
Ryosuke Takahashi
J
Jun Takahashi
Article Details
Journal
Nature
Volume / Issue
Vol. 641, Issue 8064
Published
May 22, 2025
Pages
971-977
ISSN
0028-0836
Publisher
Nature Portfolio
Authors (22)
N
Nobukatsu Sawamoto
D
Daisuke Doi
E
Etsuro Nakanishi
M
Masanori Sawamura
T
Takayuki Kikuchi
H
Hodaka Yamakado
Y
Yosuke Taruno
A
Atsushi Shima
Y
Yasutaka Fushimi
T
Tomohisa Okada
T
Tetsuhiro Kikuchi
A
Asuka Morizane
S
Satoe Hiramatsu
T
Takayuki Anazawa
T
Takero Shindo
K
Kentaro Ueno
S
Satoshi Morita
Y
Yoshiki Arakawa
Y
Yuji Nakamoto
S
Susumu Miyamoto
R
Ryosuke Takahashi
J
Jun Takahashi
Related Articles from this Journal
Graduating without a thesis: meet the people getting ‘practical’ PhDs in China
Xiaoying You
Jul 2026
10.1038/d41586-026-01242-z
White House rolls out AI funding — and signals a new era for US science
Dan Garisto, Kaia Glickman
Jul 2026
10.1038/d41586-026-02332-8
Personalized gene therapy relieves severe epilepsy in two boys
Jul 2026
10.1038/d41586-026-02267-0
Author Correction: Feature-specific threat coding in lateral septum guides defensive action
Dionnet Leandro Bhatti Mazo, Marc Z. C. Berger et al.
Jul 2026
10.1038/s41586-026-10911-y
Briefing Chat: Baby T. rex were killers from birth, suggest new fossils
Elizabeth Gibney, Nick Petrić Howe
Jul 2026
10.1038/d41586-026-02338-2